From Our Partners
Sunday, June 26, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

DARPA Living Foundries 1000 Molecules Award to Duke

by Global Biodefense Staff
June 11, 2014

The Defense Advanced Research Projects Agency (DARPA) has recently awarded funding to Duke University for research in support of the Living Foundries: 1000 Molecules program.

The total award value is $2,513,015 composed of a base award for $1,585,812 and option in the amount of $927,203.

The goal of the program is to develop a first-of-its-kind biotechnology infrastructure to provide new materials, flexible capabilities, and manufacturing paradigms for national security and public health.

As a demonstration of the functionality and flexibility of the infrastructure being developed, the program aims to generate 1000 unique molecules and chemical building blocks of relevance to the Department of Defense by the end of the program’s period of performance.

Other organizations previously awarded contracts for the 1000 Molecules program include:

  • Massachusetts Institute of Technology $124,072
  • Harvard $512,930
  • Twist Bioscience Corporation $5,119,656
  • University of Illinois $239,980
  • University of Colorado $189,535
  • 20n Labs, Inc. $699,453

Living Foundries: 1000 Molecules is complementary to and builds upon the Living Foundries: Advanced Tools and Capabilities for Generalizable Platforms (ATCG) program, which is developing new tools and technologies to accelerate the biological design-build-test cycle. Together, these programs will leverage biology as a technology platform to pursue transformative applications across chemicals, materials, sensing capabilities, and therapeutics.

The DARPA Living Foundries: 1000 Molecules Program Broad Agency Announcement remains open until February 2, 2015.

From Our Partners
Tags: AwardsDARPA

Related Posts

BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV
Health Security

Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit

June 2, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Federal Select Agent Program Clarifies Requirements for Botulinum Neurotoxin Gene Constructs
Health Security

Federal Select Agent Program Clarifies Requirements for Botulinum Neurotoxin Gene Constructs

May 4, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC